Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in TMJ Arthralgia
NCT01995019Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Dec 2013
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in temporomandibular joint arthralgia, sponsored by Uppsala University. Started Dec 2013; status: completed.
02
Drugs
methylprednisolone
03
Conditions
temporomandibular joint arthralgia
Beyond the preview
Go deeper on NCT01995019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01995019.